ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01229865
Recruitment Status : Unknown
Verified March 2015 by Vascular Biogenics Ltd. operating as VBL Therapeutics.
Recruitment status was:  Active, not recruiting
First Posted : October 28, 2010
Last Update Posted : March 27, 2015
Sponsor:
Information provided by (Responsible Party):
Vascular Biogenics Ltd. operating as VBL Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Actual Primary Completion Date : October 2014
  Estimated Study Completion Date : June 2016